News
Sarepta Therapeutics defies the FDA’s request to stop all shipments of Elevidys; Biogen plops down $2B investment in NC; George Tidmarsh becomes FDA director of CDER.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback